Detalhe da pesquisa
1.
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.
Nat Commun
; 15(1): 1652, 2024 Feb 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38396069